Shopping Cart

Remove All

Your shopping cart is currently empty

Proceed to checkout Continue shopping

Rilmenidine hemifumarate

Name: Rilmenidine hemifumarate
Brand: TargetMol
SKU: T21911
Rating: 4.5 (1 reviews)

Copy Product Info

😃Good

Catalog No. T21911Cas No. 207572-68-7

Alias S-3341 hemifumarate, Rilmenidine (hemifumarate)

Rilmenidine hemifumarate (S-3341 hemifumarate) is a novel, orally active and selective I1 imidazoline receptor and α2-adrenoceptor agonist that induces autophagy, regulates the proliferation of leukaemia cells, stimulates the pro-apoptotic protein Bax, and induces autophagy in human leukaemia K5 cells. induces disruption of the mitochondrial pathway and apoptosis in human leukaemia K562 cells.

Rilmenidine hemifumarate

Copy Product Info

😃Good

Purity: 98.14%

Catalog No. T21911Alias S-3341 hemifumarate, Rilmenidine (hemifumarate)Cas No. 207572-68-7

Pack Size	Price	USA Warehouse	Global Warehouse
5 mg	$72	1-2 weeks	1-2 weeks
10 mg	$98	1-2 weeks	1-2 weeks
25 mg	$168	1-2 weeks	1-2 weeks
50 mg	$247	1-2 weeks	1-2 weeks
100 mg	$365	1-2 weeks	1-2 weeks

Add to Cart

Add to Quotation

In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Questions

Batch Information

Select Batch

Purity:98.14%

Appearance:Solid

Color:White

Resource Download

COA HPLC

Product Introduction

Bioactivity

Description	Rilmenidine hemifumarate (S-3341 hemifumarate) is a novel, orally active and selective I1 imidazoline receptor and α2-adrenoceptor agonist that induces autophagy, regulates the proliferation of leukaemia cells, stimulates the pro-apoptotic protein Bax, and induces autophagy in human leukaemia K5 cells. induces disruption of the mitochondrial pathway and apoptosis in human leukaemia K562 cells.
In vitro	Rilmenidine offers antihypertensive efficacy comparable to diuretics, beta-blockers, calcium channel blockers, and angiotensin-converting enzyme (ACE) inhibitors. Rilmenidine (25-100 μM; 24 hours) also inhibits K562 cell proliferation[3].
In vivo	In Rilmenidine-treated N171-82Q mice (i.p.; 4-times a week), significant improvement in forelimb grip strength and all limbs grip strength is observed from 12 to 22 weeks of age. Rilmenidine also decreases levels of mutant huntingtin[2].
Synonyms	S-3341 hemifumarate, Rilmenidine (hemifumarate)

Chemical Properties

Molecular Weight	238.28
Formula	C₁₀H₁₆N₂O.1/2C₄H₄O₄
Cas No.	207572-68-7
Smiles	C1CC1C(C2CC2)NC3=NCCO3.C1CC1C(C2CC2)NC3=NCCO3.C(=CC(=O)O)C(=O)O
Relative Density.	no data available

Storage & Solubility Information

Storage

store at low temperature,store under nitrogen | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Solubility Information

H2O: 30 mg/mL (125.9 mM), Sonication is recommended.

DMSO: 5 mg/mL (20.98 mM), Sonication is recommended.

Solution Preparation Table

DMSO/H2O

	1mg	5mg	10mg	50mg
1 mM	4.1967 mL	20.9837 mL	41.9674 mL	209.8372 mL
5 mM	0.8393 mL	4.1967 mL	8.3935 mL	41.9674 mL
10 mM	0.4197 mL	2.0984 mL	4.1967 mL	20.9837 mL
20 mM	0.2098 mL	1.0492 mL	2.0984 mL	10.4919 mL

H2O

	1mg	5mg	10mg	50mg
50 mM	0.0839 mL	0.4197 mL	0.8393 mL	4.1967 mL
100 mM	0.0420 mL	0.2098 mL	0.4197 mL	2.0984 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:

For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments

and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent

10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH₂O , the resulting working solution concentration would be 2 mg/mL.

Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSO TargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSO TargetMol | reagent stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH₂O TargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.

All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc